Brief: Gubra Submits Clinical Trial Application For GUB-UCN2 In Germany
26/02/2026 06:31
Feb 26 (Reuters) - Gubra A/S GUBRA.CO: SUBMITS CLINICAL TRIAL APPLICATION FOR GUB-UCN2 IN GERMANY GUB-UCN2 EXPECTED TO ENTER CLINICAL DEVELOPMENT IN FIRST HALF OF 2026 PHASE 1/2A TRIAL TO EVALUATE GUB-UCN2'S SAFETY AND EFFICACY Source text: ID:nMFNXhZWB Further company coverage: GUBRA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))